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T he poliovirus receptor (PVR) is a ubiquitously expressed glycoprotein involved in cellular adhesion and immune response. It
engages the activating receptor DNAX accessory molecule (DNAM)-1, the inhibitory receptor TIGIT, and the CD96 receptor
with both activating and inhibitory functions. Human cytomegalovirus (HCMV) down-regulates PVR expression, but the significance of this viral function in vivo remains unknown. Here, we demonstrate that mouse CMV (MCMV) also down-regulates
the surface PVR. The m20.1 protein of MCMV retains PVR in the endoplasmic reticulum and promotes its degradation. A
MCMV mutant lacking the PVR inhibitor was attenuated in normal mice but not in mice lacking DNAM-1. This attenuation
was partially reversed by NK cell depletion, whereas the simultaneous depletion of mononuclear phagocytes abolished the virus
control. This effect was associated with the increased expression of DNAM-1, whereas TIGIT and CD96 were absent on these
cells. An increased level of proinflammatory cytokines in sera of mice infected with the virus lacking the m20.1 and an increased production of iNOS by inflammatory monocytes was observed. Blocking of CCL2 or the inhibition of iNOS significantly
increased titer of the virus lacking m20.1. In this study, we have demonstrated that inflammatory monocytes, together with
NK cells, are essential in the early control of CMV through the DNAM-1–PVR pathway.

INTRODUCTION
Cytomegaloviruses (CMVs) are species-specific herpesviruses
causing severe disease in immunocompromised and immunologically immature hosts. Mouse CMV (MCMV) is biologically similar to human CMV (HCMV), and therefore serves as
a widely used model for studying CMV pathogenesis (Reddehase, 2002). Cells of the innate immune system play a crucial
role in cytomegaloviral control before the initiation of specific
immunity (Vidal et al., 2013). NK cells represent an essential
component of innate immunity as a result of their ability to
identify infected cells via a set of signals provided by activating
and inhibitory receptors (Shifrin et al., 2014). The mononuclear phagocyte system is composed of monocytes, macrophages, and DCs. Monocytes are highly adaptable cells that can
differentiate into monocyte-derived macrophages and monocyte-derived DCs (Chow et al., 2011). Macrophages are professional phagocytic cells whose main function is to inactivate
*T. Lenac Rovis and P. Kucan Brlic contributed equally to this paper.

and destroy invading pathogens (Martinez and Gordon, 2014).
A direct macrophage infection in lymph node results in limiting CMV spread (Farrell et al., 2015). Following their genetic
programs, instructed in part by their tissue microenvironment
and by the signals gathered through their receptors, mononuclear phagocytes can adopt a variety of specific functional
programs, encompassing, but not limited to, the well-known
M1 versus M2 phenotypes (Italiani and Boraschi, 2014; Murray et al., 2014).The M1, with its proinflammatory features, is
protective against viruses and other intracellular parasites.This
phenotype is associated with the production of proinflammatory cytokines such as IFN-γ or IL-12 and activation of inducible nitric oxide synthase (iNOS)–NO pathway. Alternatively,
mononuclear phagocytes can polarize to M2 cells associated
with IL-4 and arginase production. Although the polarization
of mononuclear phagocytes may be essential for ultimate virus
control, the mechanisms used by various viruses to regulate
this cellular programming are still insufficiently characterized.
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RESULTS
MCMV retains PVR in infected cells and
prevents its surface expression
Our first goal was to assess whether MCMV, like HCMV,
interferes with the PVR expression. Although the transcrip1836

tion of PVR during MCMV infection was increased (Fig. 1,
A and B, left; Juranic Lisnic et al., 2013), and WT MCMV
infection resulted in up-regulation of PVR transcript compared with mock-infected control, we found the surface level
of PVR to be reduced upon MCMV infection of primary
MEF (Fig. 1, B [right] and C). Similar down-regulation of
surface PVR was confirmed on several cell lines infected with
MCMV (Fig. 1 D). In contrast, UV inactivated virus did not
down-regulate PVR, and the kinetics of PVR reduction suggested that a viral gene product expressed early after infection
is responsible for PVR down-regulation (unpublished data).
Next, we analyzed the molecular mechanism involved in
viral PVR down-regulation. The molecular mass of the mature PVR protein in uninfected cells is between 80 and 90 kD
(Fig. 2 A). However, the infection with MCMV resulted in the
accumulation of a lower molecular form of PVR of ∼70 kD
(Fig. 2 A).The treatment of lysates of MCMV-infected cells with
EndoH revealed that the 70-kD protein form is EndoH sensitive,
implying that MCMV retains PVR inside the cell (Fig. 2 B).
Inhibitors of cellular degradation pathways were tested, and increased PVR amounts were seen in infected cells treated with
lactacystin, an inhibitor of proteosomal degradation, whereas the
lysosomal inhibitor leupeptin had minimal or no effect (Fig. 2 C).
The dominance of the proteasomal degradation was further
confirmed by confocal microscopy (Fig. 2 D). These data show
that, similar to HCMV, MCMV retains PVR in the ER, prevents
its maturation, and initiates its degradation in the proteasome.
Recently, it has been shown that DCs and macrophages
up-regulate PVR expression upon MCMV infection (Nabekura
et al., 2014).To check whether MCMV also retains the PVR in
cells other than primary fibroblasts, different cell lines were infected with WT MCMV, and their lysates were analyzed for PVR
retention. As shown in Fig. 2 E, the PVR retention was evident
in all cell lines tested, including BM-derived DCs (BMDCs), the
DC cell line DC2.4, and macrophage cell line J774. Testing the
PVR retention in cells infected with field isolates of MCMV
(Smith et al., 2008) showed the same PVR retention phenomenon (Fig. 2 F).Thus, PVR retention is conserved between various MCMV strains and functional in different cell types.
Characterization of the MCMV protein
involved in PVR regulation
The next goal was to identify and characterize MCMV genes
involved in PVR retention. Using a library of MCMV mutants
with genomic deletions, we could show that the gene responsible for the PVR retention is located in the m01-m22 gene
region (Δ8 virus, Fig. 3 A). Because PVR maturation in cells
infected with an MCMV mutant lacking the segment of first 17
genes (Δ1 virus) was comparable with the WT MCMV, we concluded that the PVR regulator must lie in the m18-m22 gene
region (Fig. 3 A). To determine the role of individual genes in
this region, according to previously annotated ORFs (Rawlinson et al., 1996), we constructed MCMV mutants with deletions
in the genes m18, m19, m21, or m22 (Fig. 3 B, top). Because
ORF m20 significantly overlaps with ORFs m19 and m21, it
MCMV evasion of DNAM-1-dependent immune control | Lenac Rovis et al.
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The poliovirus receptor (PVR or CD155), a member of
the nectin protein family, serves as a ligand for the adhesion molecule DNAX accessory molecule 1 (DNAM-1; CD226; Shibuya
et al., 1996; Bottino et al., 2003). DNAM-1 is an activating receptor expressed on the majority of immune cells, including
monocytes, T cells, NK cells, and as a subset of B cells (Shibuya
et al., 1996; Bottino et al., 2003; Chan et al., 2014; de Andrade et
al., 2014;Vo et al., 2016). Upon recognition of its ligands, CD155
(PVR) and CD112 (Nectin-2), DNAM-1 promotes NK cell
activation and elimination of infected cells (de Andrade et al.,
2014). Recent data revealed that DNAM-1 expression marks
an alternative maturation program of NK cells (Martinet et al.,
2015) and plays a role in the generation of memory NK cells
(Nabekura et al., 2014). However, the role of DNAM-1 in virus
control by various subsets of mononuclear phagocytes has not
been so far established. PVR is also a high affinity ligand for TIG
IT, a receptor that inhibits NK and T cell cytotoxicity (Stanietsky et al., 2009, 2013;Yu et al., 2009; Joller et al., 2011; Levin et
al., 2011). Moreover, PVR binds to the CD96 (Tactile) receptor
with both activating and inhibitory functions on NK cells (Fuchs
et al., 2004; Chan et al., 2014). The functional outcome of a simultaneous PVR ligation of activating and inhibitory receptors
on immune cells and virus control is therefore hard to predict.
This becomes even more evident if we consider that PVR is
expressed on the majority of somatic cells under physiological
conditions and that its expression is induced as a consequence of
viral infections and tumorigenesis (Chadéneau et al., 1994; Gromeier et al., 2000; Masson et al., 2001; Hirota et al., 2005;Tomasec et al., 2005; Magri et al., 2011;Vassena et al., 2013; Nabekura
et al., 2014). Cells up-regulate PVR expression in response to
Ras activation and DNA damage response pathway, as well as
Toll-like receptor activation (Hirota et al., 2005; Soriani et al.,
2009; Kamran et al., 2013;Vassena et al., 2013).
HCMV encodes a protein that reduces PVR surface expression on infected cells (Tomasec et al., 2005), but the impact
of this viral function on virus control in vivo could not be addressed due to the strict species specificity of HCMV. To overcome this limitation and assess the relevance of viral regulation of
PVR for virus control, we have used the infection of mice with
MCMV.We have observed that, similar to HCMV, MCMV also
retains PVR inside of infected cells, and we have characterized
the viral gene involved. The deletion of the MCMV inhibitor
of PVR dramatically enhances the virus susceptibility to innate
immune control in DNAM-1–dependent manner.This function
is partially dependent on NK cells that express both inhibitory
and activating PVR receptors, but the virus control also strongly
depends on mononuclear phagocytes that display a dramatic increase of DNAM-1 expression upon infection and, at the same
time, fail to express inhibitory PVR receptors.

Figure 1. MCMV up-regulates PVR transcription but
down-regulates its surface expression. (A) PVR locus
with aligned reads from RNASeq analysis of infected and
mock-infected MEF (Juranic Lisnic et al., 2013; left). Estimation of PVR gene expression by RPKM (reads per kilobase of exon model per million mapped reads; right). (B)
Level of PVR transcript was measured in mock-infected
BALB/c MEF and in WT MCMV-infected cells (left) that
down-regulated PVR after 18 h p.i. (right) by quantitative RT-PCR. Data are representative from two independent experiments. ***, P < 0.001. (C) WT MCMV (1 PFU/
cell, 16 h) or mock-infected MEFs were analyzed for the
surface PVR by anti-PVR mAb or the isotype control. (D)
Indicated cell lines, WT MCMV (3 PFU/cell, 16 h) or mock
infected, were analyzed for the surface PVR expression.
The analysis of surface PVR expression (C and D) was independently replicated six times.
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lates PVR, we expressed fragments of the predicted m20 protein as His-tagged proteins in Escherichia coli and used them
as antigens to immunize mice.The newly generated mAb detected an MCMV protein in lysates of WT MCMV-infected
cells but not in lysates derived from cells infected with the
Δm20.1 mutant (Fig. 4 A). A dominant signal for an ∼70-kD
protein and a weak signal for a 55-kD form were observed.
Endo H treatment of the 70 kD protein, named m20.1, increased the amount of its deglycosylated form of ∼55 kD
(Fig. 4 B). By immunoblotting PVR and m20.1 in the lysates
of MEF cells infected with WT MCMV or Δm20.1 mutant, we demonstrated that the retained PVR form is present
only in cells infected with virus possessing an intact m20.1
(Fig. 4 C). In parallel, we tested the expression of PVR on the
surface of infected MEF cells by flow cytometry and showed
that the virus lacking m20.1 cannot down-regulate PVR
(Fig. 4 D). In agreement with published work (Nabekura et
al., 2014), the infection of primary DCs with WT MCMV
resulted in the up-regulation of PVR expression. However,
the PVR expression was still much lower than expression on
the surface of cells infected with the virus lacking PVR inhibitor (Fig. 4 D). Finally, we confirmed that m20.1 protein is
required for PVR retention showing the protein–protein in1837
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was not feasible to construct individual deletion mutants for m19
and m21 ORFs. MEF was infected with indicated mutants and
analyzed for PVR retention. Only the MCMV mutants lacking
ORFs m19 and m20 (Δm19/m20) and ORFs m20 and m21
(Δm20/m21) were unable to retain PVR (Fig. 3 C). This result
strongly suggested a role of m20 in PVR regulation.
Our previous analysis of the transcriptional profile of the
m20 region (Juranic Lisnic et al., 2013) detected several overlapping transcripts. Consistent with these data, a RNA probe
detected three dominant transcripts for the WT virus: transcripts
of ∼3, 2, and 1 kb (Fig. 3 D, left). Because in the available viral
mutants, either all or none of those transcripts were missing (not
depicted), three additional viral mutants were generated to identify the transcript involved in PVR regulation (Fig. 3 B, bottom).The transcriptional profile of the deletion mutant Δm19.1
and of WT MCMV was identical, whereas the Δm20.0 mutant
gave no detectable transcripts (Fig. 3 D, right). The transcriptional profile of Δm20.1 virus showed a loss of the 2- and 3-kb
transcripts, whereas the 1-kb transcript was preserved (Fig. 3 D).
As can be seen from the Western blot analysis in Fig. 3 E, this
Δm20.1 mutant was no longer able to retain the PVR.
To investigate whether the m20 region corresponding
to the 2- and 3-kb transcripts encodes the protein that regu-

teraction between the m20.1 and the ER retained PVR form
of ∼70 kD by coimmunoprecipitation (Fig. 4 E). Altogether,
we have characterized the viral protein encoded in the m20
gene region and proved that the ER-resident glycoprotein
m20.1 is responsible for PVR retention.
In vivo attenuation of the MCMV mutant lacking the PVR
inhibitor is partially mediated by NK cells
The next aim was to assess whether CMV regulation of
PVR has functional relevance in vivo. BALB/c mice were
1838

i.v. injected with Δm20.1 mutant or the respective control virus and viral titers in organs were determined 4 d
p.i. (Fig. 5 A). The virus lacking the PVR inhibitor was
strongly attenuated in vivo. Attenuation levels were similar in immunocompetent animals, as well as in SCID mice,
suggesting a crucial role of innate immune cells in the control of the Δm20.1 virus (Fig. 5 B). These results indicate
that viral regulation of PVR inhibits the early virus control
in vivo. The infection of newborn mice, which are still immunologically immature and very sensitive to MCMV inMCMV evasion of DNAM-1-dependent immune control | Lenac Rovis et al.
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Figure 2. MCMV blocks PVR maturation in the ER and promotes its proteasomal degradation. (A) PVR was immunoblotted from WT MCMV (1 PFU/
cell, 20 h) or mock infected MEF lysates with anti-PVR mAb; actin is shown as a loading control and MCMV m04 protein as a control of infection. Immunoblotting was independently replicated six times. (B) B12 cells were infected with WT MCMV (3 PFU/cell, 16 h) or mock infected. PVR was immunoblotted from
EndoH-treated or untreated lysates (top); actin is shown as a loading control and MCMV M57 protein as a control of infection (bottom). (C) B12 cells were
infected with WT MCMV (3 PFU/cell) and at 4 h p.i. treated with lactacystin (10 µM), leupeptin (75 µg/µl) or left untreated. 16 h p.i. lysates were analyzed
with anti-PVR mAbs; actin is shown as a loading control. (D) B12 cells were infected with the virus lacking viral Fc receptor m138, treated as indicated for
C and analyzed with anti-PVR mAbs, followed by FITC-labeled secondary Abs by IF. All images were equally adjusted using FluoView software; γ adjustment,
1.8; bar, 10 µm. Experiments with lactacystin and leupeptin were independently replicated two times. (E) PVR was immunoblotted from mock or WT MCMV
(3 PFU/cell, 20 h) infected lysates of indicated cells; actin is shown as a loading control. (F) PVR was immunoblotted from lysates of B12 cells infected with
WT MCMV or three field isolates (2.5 PFU/cell, 16 h); actin is shown as a loading control. PVR immunoblotting (E and F) was repeated independently on each
cell line at least two times.

fection, also results in attenuation of mutant virus in several
tested organs (Fig. 5 C).
To assess whether the attenuated phenotype of the
Δm20.1 mutant is the result of an enhanced sensitivity to NK
cells, BALB/c and C57BL/6 mice were infected with either
Δm20.1 or control virus. Several mice in each group were
depleted of NK cells, and virus titers were determined on day
4 p.i. (Fig. 5 E).The results clearly demonstrated that NK cells
contribute to efficient control of a virus lacking the PVR inhibitor, to varying extents depending on the tissue examined.
These in vivo findings are in accordance with enhanced proJEM Vol. 213, No. 9

duction of IFN-γ by NK cells derived from Δm20.1-infected
mice compared with cells derived from mice infected with the
control virus (Fig. 5 D). However, there were still significant
differences between the titer of control virus and the Δm20.1
mutant after NK cell depletion, indicating that additional innate immune control mechanisms are involved (Fig. 5 E).
Dominant expression of DNAM-1 on inflammatory
monocytes and macrophages after MCMV infection
The enhanced susceptibility of MCMV lacking the PVR inhibitor to immune control indicates a role of the DNAM-1–
1839
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Figure 3. PVR is regulated by a gene located in the m20 gene region. (A) B12 cells were infected with WT, Δ8 (Δm01-m22) or Δ1 (Δm01-m17) MCMV
(3 PFU/cell) and immunoblotted with anti-PVR mAbs; actin is shown as a loading control. (A and B) White boxes represent deleted gene regions in recombinant viruses. (B) Previously annotated ORFs are shown as white arrows. The black arrow represents the RNA probe used for the Northern blot analysis
in D. (C) PVR was immunoblotted from lysates of B12 cells infected with indicated mutants (3 PFU/cell, 16 h); actin is shown as a loading control. (D) MEF
was infected with indicated viruses (0.3 PFU/cell, 48 h) or left uninfected. Transcripts were identified using the RNA probe (B). WT MCMV lane is from different gel, whereas Δm19.1, Δm20.0 and Δm20.1 are parts of the same gel analyzed with the same exposure. (E) MEF was infected with indicated viruses
(1 PFU/cell, 20 h). PVR was immunoblotted from cell lysates. All experiments (A–E) were independently replicated at least two times.

PVR pathway. Thus, we analyzed the expression of PVR
receptors on NK cells and mononuclear phagocytes (Fig. 6,
A–C). We found that the frequency of NK cells expressing
DNAM-1 is higher in mice infected with MCMV, irrespective of the virus used.Yet the frequency of NK cells expressing
TIGIT was also significantly higher in infected mice, whereas
the frequency of CD96+ NK cells was significantly lower
(Fig. 6 A).This fact might explain why NK cells fail to control
Δm20.1 more efficiently. In contrast to NK cells, mononuclear
phagocytes express almost no other PVR receptors except
DNAM-1 (Fig. 6 B and not depicted). Moreover, we found
that upon infection, the frequency of DNAM-1–expressing
inflammatory monocytes (Fig. 6 B) and splenic macrophages
1840

(Fig. 6 C) was dramatically increased. The surface density of
DNAM-1 on all splenic macrophage subsets (including red
pulp, marginal metallophilic, and marginal zone macrophages)
was up-regulated upon infection (Fig. 6 C, bottom). Based on
the pattern of expression of DNAM-1,TIGIT, and CD96 on
mononuclear phagocytes, it appears to assume dominance of
DNAM-1 in virus control.
Mice infected with Δm20.1 have higher level of
proinflammatory cytokines in sera, as well as increased
production of nitric oxide by inflammatory monocytes
Cytokine profiles in the sera of Δm20.1-infected mice were
in line with a more efficient antiviral activity (Fig. 6 D). AlMCMV evasion of DNAM-1-dependent immune control | Lenac Rovis et al.
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Figure 4. Characterization of the viral
protein m20.1 that retains PVR. (A) m20.1
was immunoblotted from MCMV (indicated viruses, 1 PFU/cell, 20 h) or mock infected MEF
lysates with anti-m20.1 mAb; actin is shown
as a loading control and MCMV m04 protein
as a control of infection. (B) MEF was infected
with indicated viruses (0.8 PFU/cell; 20 h).
MCMV m20.1 and m04 proteins were immunoblotted from EndoH-treated or untreated
lysates with corresponding Abs; m04 is shown
as a control of infection and EndoH treatment.
(C) B12 cells were infected with indicated viruses (3 PFU/cell, 20 h) or mock infected. PVR
and m20.1 proteins were immunoblotted from
lysates with rat anti–mouse PVR mAb and
anti-MCMV m20.1 mAb, respectively. Actin
is shown as a loading control and m04 as a
control of viral infection. Different parts of
the same gel analyzed by same exposure are
shown. (D) BMDCs or MEF cells were infected
with either WT MCMV or Δm20.1 virus (3 or
1 PFU/cell, respectively). Infected and mock
infected cells were analyzed for the surface
PVR by anti-PVR mAb, or the isotype control,
followed by anti–rat PE. (E) PVR was immunoblotted from MCMV-infected MEF lysates
with anti-PVR mAb (left). The m20.1 was immunoprecipitated from the same lysates with
the anti-m20.1 mAb or the control mAb, and
PVR was subsequently immunoblotted from
precipitates with anti-PVR mAb (right). All
experiments (A–E) were independently replicated at least two times.
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Figure 5. Heavy attenuation of MCMV lacking PVR inhibitor is caused in part by NK cells. BALB/c mice (A) or C57BL/6 SCID mice (B) were i.v. injected
with 2 × 105 PFU/mouse (A) or 5 × 105 PFU/mouse (B) of Δm20.1 MCMV mutant generated on Δm157 background and Δm157 MCMV as a control virus.
Titers in organs of individual mice 4 d p.i. are shown (circles); horizontal bars indicate the median values. (C) Newborn BALB/c mice were i.p. injected with
400 PFU/mouse of Δm20.1 MCMV mutant generated on Δm157 background or Δm157 MCMV. Titers in organs of individual mice 11 d p.i. are shown (circles); horizontal bars indicate the median values. Results from one of the three independent experiments (A) and one of the two independent experiments
(B and C) are shown, with minimum four animals per group. DL, detection limit. *, P < 0.05; **, P < 0.01. (D) BALB/c mice were i.v. injected with 2 × 105 PFU
of WT MCMV, Δm20.1 MCMV, or left uninfected. IFN-γ expression by splenic NK cells was determined by intracellular FACS analysis 1.5 d p.i. n = 5 animals;
mean + SD; *, P < 0.05. Data are representative from three independent experiments. (E) C57BL/6 or BALB/c mice depleted for NK cells or undepleted were
i.v. injected with 5 × 105 PFU/mouse or 2 × 105 PFU/mouse of Δm157 MCMV (control virus) or Δm20.1 mutant generated on Δm157 background. Titers in
organs of individual mice 4 d p.i. are shown (circles); horizontal bars indicate the median values. Results from one of the two independent experiments with
minimum three animals per group are shown. *, P < 0.05; **, P < 0.01.

though we were unable to define which subpopulations of
mononuclear phagocytes are responsible for differences in
cytokine production between WT- and Δm20.1-infected
mice, the sera of Δm20.1-infected mice 1.5 d p.i. showed
JEM Vol. 213, No. 9

increased level of IL-12p70, G-CSF, and IL-6, cytokines characteristic for the proinflammatory response of M1 mononuclear phagocytes (Martinez and Gordon, 2014). The level of
IFN-γ, a major NK cell cytokine and an important activator
1841

of mononuclear phagocytes that is induced upon DNAM-1
signaling (de Andrade et al., 2014), was also elevated in the
sera of mice infected with Δm20.1 (Fig. 6 D). Accordingly,
the levels of IL-10, a hallmark of antiinflammatory response
and inhibition of proinflammatory cytokine expression in
1842

macrophages (Martinez and Gordon, 2014), were reduced in
the sera of mice infected with Δm20.1 virus. The decrease
was also observed for the CXCL13, IL-10–induced chemoattractant, and the antiinflammatory cytokine tissue inhibitor
of metalloproteinases (TIMP-1). The level of another proinMCMV evasion of DNAM-1-dependent immune control | Lenac Rovis et al.
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Figure 6. Macrophages and inflammatory
monocytes in spleen selectively up-regulate
PVR receptor DNAM-1 upon CMV infection.
(A) BALB/c mice were i.v. injected with 2 × 105 PFU
of WT MCMV, Δm20.1 MCMV, or left uninfected.
1.5 d p.i. percentages of DNAM-1+, CD96+, or
TIGIT+ NK cells were determined from spleen by
surface FACS analysis. (B) Mice were i.p. injected
with 2 × 105 PFU of WT MCMV, Δm20.1 MCMV,
or left uninfected and the expression of DNAM1, CD96, and TIGIT determined on inflammatory
monocytes by FACS analyses. (C) BALB/c mice were
treated as described in B, and the expression of
DNAM-1 on splenic macrophages determined by
FACS analyses (RP, red pulp; MM, marginal metallophilic; MZ, marginal zone macrophages). (D) Dot
blot analysis of cytokines, with capture antibodies spotted onto a membrane, in the sera of mice
infected with WT MCMV or Δm20.1 MCMV. Two
membranes with 40 different antibodies captured
(in duplicate) were tested in each experiment with
the sera of either WT MCMV or Δm20.1 MCMV infected mice. Experiment was repeated twice with
different sera. Data selected for cytokines that
were consistently up-regulated or down-regulated
in both experiments and whose fold change was
≥2 in at least one of the experiments (*). Shown
are mean values plus range. (E) BALB/c mice were
treated as described in B. 1.5 d p.i. iNOS expression
by inflammatory monocytes was determined by
intracellular FACS analysis. (A and B [top] and C
and E) n = 5 animals per group; mean + SD. *, P <
0.05; **, P < 0.01; ***, P < 0.001.

flammatory cytokine secreted by macrophages, IL-1, was not
evidently different; however, Δm20.1-infected mice had a
lower amount of the IL-1 receptor antagonist (IL-1ra). Thus,
the data indicate that m20.1 down-regulates the proinflammatory cytokine response via the PVR–DNAM-1 pathway.
Because cytokines induce iNOS to produce NO as an
important effector mechanism of mononuclear phagocytes,
we compared the production of iNOS by all major subsets
of splenic mononuclear phagocytes, including red pulp macrophages, marginal metallophilic macrophages, and marginal
zone macrophages, conventional DCs, plasmacytoid DCs, and
inflammatory monocytes derived from mice infected with
Δm20.1 or control MCMV (Fig. 6 E and not depicted). Inflammatory monocytes produced more iNOS after infection
with Δm20.1 virus compared with WT MCMV (Fig. 6 E),
suggesting their dominant role in observed phenotype in vivo.

JEM Vol. 213, No. 9

DISCUSSION
While the outcome of viral down-regulation of cellular ligands
for the activating receptors can be predicted, the situation is
more complex for ligands such as PVR, which are recognized
by both activating and inhibitory receptors (Martinet and
Smyth, 2015). The outcome depends not only on the level of
ligand down-regulation but also on the expression level and the
affinity of its respective receptors. In this study, we have shown
that the surface level of PVR is down-regulated by the MCMV
protein m20.1, which affects the maturation of PVR in the
ER, leading to its proteasomal degradation.The virus mutants
lacking a PVR inhibitor are severely attenuated in vivo, indicating the dominance of the activating receptor DNAM-1 in
deciding the outcome of the modulation of PVR levels. The
early attenuation of mutant viruses lacking the PVR inhibitor
was only partially dependent on NK cells, which can be explained by the fact that these cells induce both activating and
inhibitory PVR receptors upon infection. However, the depletion of mononuclear phagocytes abolished the virus control,
which correlates with dramatic up-regulation of DNAM-1
and absence of inhibitory PVR receptors on these cells even
upon infection. In particular, we identified CCL2-dependent
inflammatory monocytes as a major subpopulation controlling
the virus lacking the PVR inhibitor via induction of iNOS.
Given that HCMV also retains PVR (Tomasec et al.,
2005), one can assume that PVR regulation by this virus has
a similar impact on the virus control as the one shown for
the MCMV. Interestingly, in HCMV, the gene that regulates
PVR, UL141, also inhibits the expression of another ligand
of DNAM-1, nectin-2 (CD112; Prod’homme et al., 2010).
In contrast, MCMV m20.1 solely regulates PVR, whereas
another, thus far unidentified gene, is involved in the regulation of nectin-2 (unpublished data). Although HCMV and
MCMV use different genes for regulation of PVR, the same
functional outcome indicates the importance of DNAM-1 in
virus control. It has been shown that inhibitory receptor TIG
IT has a much stronger affinity for PVR than activating receptor DNAM-1 (Yu et al., 2009), and this might have functional
consequences during CMV infection. Here, we demonstrated
that MCMV infection partially reduces the PVR expression
instead of its complete abolishment from the cell surface.This
pattern is preserved even in cells that up-regulate PVR surface
levels upon MCMV infection, such as DCs (this study and
Nabekura et al., 2014).Thus, in all infected cells, the PVR expression after Δm20.1 MCMV infection exceeded the levels
that were observed after WT MCMV infection. We hypoth1843
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DNAM-1– and iNOS-dependent attenuation of Δm20.1
by inflammatory monocytes
To assess the role of DNAM-1 in the early attenuation of
Δm20.1, we used DNAM-1−/− mice (Gilfillan et al., 2008).
In mice lacking DNAM-1, the differences in virus titers
between WT and Δm20.1 virus were reduced or abolished
(Fig. 7 A). These findings are in accordance with the data obtained on iNOS production in DNAM-1−/− mice (Fig. 7 B).
Whereas in C57BL/6 mice the frequency of iNOS+ inflammatory monocytes was higher upon Δm20.1 infection compared with the WT MCMV infection, this difference was
abolished in DNAM-1−/− mice.
To further confirm the contribution of mononuclear
phagocytes in the control of virus lacking PVR inhibitor, we
treated infected mice with clodronate liposomes (Fig. 7 C).
The treatment resulted in an increase of the WT virus titer,
yet the increase of Δm20.1 virus titer was much more dramatic. Moreover, the treatment resulted in abolishment of
the difference in titers between Δm20.1 and WT MCMV
virus (Fig. 7 C). In agreement with the results shown in
Fig. 5 E, the depletion of NK cells significantly affected
the virus control, but the differences in virus titers between
WT- and Δm20.1 MCMV-infected mice depleted of NK
cells were still statistically significant. The simultaneous depletion of NK cells and mononuclear phagocytes by clod
ronate liposomes was necessary to abolish virus control in
the spleen. These results indicate that, in addition to NK
cells, mononuclear phagocytes play a role in attenuation of
virus lacking PVR inhibitor.
To evaluate the impact of inflammatory monocytes that
show higher level of iNOS expression in mice infected with
Δm20.1 MCMV (Figs. 6 E and 7 B), we blocked CCL2, a
chemokine required for exit of these cells from the BM and
their recruitment to the inflamed tissue. Mice were treated
with blocking anti-CCL2 antibodies, and virus titers were
determined 4 d p.i. (Fig. 7 D). The blocking of CCL2 increased the titer of Δm20.1 and abolished the differences between viruses in spleen, whereas in liver the blocking effect

was partial. To further confirm that the differential levels of
iNOS can explain the attenuation of Δm20.1 virus, we performed blocking of the iNOS–NO pathway by treating the
mice with the inhibitor N(G)-nitro-l-arginine methyl ester
(l-NAME; Fig. 7 E). Our results demonstrate that blocking
of iNOS production in vivo significantly increased the titer of
the virus lacking PVR inhibitor but had no significant effect
on the titer of WT MCMV virus.
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Figure 7. DNAM-1– and iNOS-dependent control of Δm20.1 MCMV by inflammatory monocytes. (A) C57BL/6 or DNAM−/− mice were i.v. injected
with 5 × 105 PFU of Δm157 MCMV (control virus) or Δm20.1 mutant generated on Δm157 background. Titers in organ of individual mice 4 d p.i. are
shown (circles); horizontal bars indicate the median values; Results from one of the two independent experiments with minimum four animals per group
are shown. *, P < 0.05. (B) C57BL/6 or DNAM−/− mice were i.p. injected with 5 × 105 PFU of Δm157 MCMV (control virus), Δm20.1 mutant generated on
Δm157 background, or left uninfected. 1.5 d p.i. iNOS expression by inflammatory monocytes was determined by intracellular FACS analysis. n = 5 animals;
mean + SD; *, P < 0.05. (C) BALB/c mice were injected i.v. with 2 × 105 PFU of indicated viruses. For depletion of NK cells, mononuclear phagocytes or both
subsets, groups of mice were treated with anti-AGM1, clodronate liposomes, or both, and virus titers were determined 4 d p.i. Group of mice injected with
PBS was used as control. Results from one of the three independent experiments with minimum four animals per group are shown. Shown are mean values
plus SEM. *, P < 0.05; **, P < 0.01. (D) BALB/c mice were injected i.p. with 2 × 105 PFU of indicated viruses. 1 d before infection and on the day of infection,
in vivo blocking of CCL2 was performed by i.p. injection of the mAbs to CCL2. Titers in organs of individual mice 4 d p.i. are shown (circles). Results from
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et al., 2005; Crane et al., 2009; Wikstrom et al., 2014). In the
sera of mice infected with the mutant lacking the PVR inhibitor, there was a shift toward proinflammatory cytokines,
such as IL-12, which is crucial for IFN-γ production in the
DNAM-1–driven response of NK cells (Magri et al., 2011).
IL-12 has been shown to have a strong stimulating effect
specifically on DNAM-1+ NK cells (Martinet et al., 2015).
In line with this, our data show that IFN-γ, the major NK
cell cytokine and an activator of macrophages, which is induced upon DNAM-1 signaling, was increased in the sera
and in the splenic NK cells of mice infected with Δm20.1.
Although it has been shown that pDCs are the main producers of IL-12 during early MCMV infection (Zucchini et
al., 2008; Alexandre et al., 2014), alternative population of
cells, such as CD11b+ DCs, can take over IL-12 production
(Dalod et al., 2003). For example, CD14+ PBMCs are the
main source of IL-12 during HCMV infection (Rölle et al.,
2014). Moreover, one has to take into account the plasticity
of the mononuclear phagocytes. On one hand, tissue macrophages polarize into M1, proinflammatory macrophages,
and on the other hand, monocyte-derived macrophages
and monocyte-derived DCs perform partially overlapping
functions, including the secretion of proinflammatory cytokines (Italiani and Boraschi, 2014). In addition, monocytes can up-regulate CD11c without converting into DCs
(Drutman et al., 2012). The discrimination of mononuclear
phagocytes and their subpopulations is further complicated
by the lack of selective markers (Gautier et al., 2012) and
by the fact that MCMV infection or TLR signaling by itself changes the surface expression of several markers, leading frequently to their down-regulation as in the case of
CD169, F4/80, CD11c, CD115, and others (Heise and Virgin, 1995; Singh-Jasuja et al., 2013; Daley-Bauer et al., 2014;
Farrell et al., 2015). Knowing that most chemokines and
cytokines can be produced by several cell types (Dalod and
Biron, 2013), and that location, timing, and overall vigor
of the immune response during CMV infection can affect
their production, further studies are needed to determine
the contribution of individual subsets to systemic cytokine
levels in MCMV-infected animals.
Proinflammatory cytokines are also involved in immunopathology. HCMV is the most common cause of
intrauterine viral infections and a major viral cause of
neurological disease in children, including disorders of
perceptual senses, such as hearing (Britt et al., 2013). A
model of MCMV-induced hearing loss also points to a
role of virus-induced inflammation (Bradford et al., 2015).
Accordingly, antiinflammatory drugs can reduce such developmental abnormalities in MCMV-infected newborn
mice (Kosmac et al., 2013). We assume that a tight con-

one of the two independent experiments with four to five animals per group are shown. *, P < 0.05. (E) BALB/c mice were injected i.v. with 2 × 105 PFU of
indicated viruses. For blocking of NOS, mice were given sterile drinking water with or without l-NAME 3 d before infection and throughout the course of
infection. Results from one of the two independent experiments with five animals per group are shown. *, P < 0.05; **, P < 0.01.
JEM Vol. 213, No. 9
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esize that MCMV might fine-tune the expression of PVR,
to avoid recognition by the activating receptor while, at the
same time, preserving ligation of the inhibitory receptor. In
any case, this strategy could not protect the virus from control
by mononuclear phagocytes, as we have shown that these cells
express almost no inhibitory PVR-ligating receptors.
Previous studies have shown that inflammatory monocytes may play a dual role in antiviral responses because their
functions can be beneficial or harmful, depending on the
model and context of infection (Iijima et al., 2011; Lim et
al., 2011; Daley-Bauer et al., 2012). In the context of CMV
infection, monocytes have mainly been identified as cellular targets for viral dissemination and latency (Mitchell et
al., 1996; Smith et al., 2004; Hargett and Shenk, 2010) or
as modulators of antiviral immune response mediated by
other immune cells (Hokeness et al., 2005; Daley-Bauer
et al., 2012). Recently, it has been shown that patrolling,
but not inflammatory, monocytes are involved in MCMV
dissemination (Daley-Bauer et al., 2014), whereas inflammatory monocytes modulate adaptive immunity to MCMV
(Daley-Bauer et al., 2012). However, less is known about
possible direct antiviral effects of inflammatory monocytes
in MCMV infection. Inflammatory monocytes use the same
mechanisms as macrophages to control viruses, such as production of inflammatory cytokines or NO (Serbina et al.,
2008), Indeed, NOS-deficient mice are more susceptible
to MCMV infection (Noda et al., 2001). In line with this,
our results show an increased iNOS production by inflammatory monocytes in mice infected with virus lacking the
PVR inhibitor, which might explain more efficient control of this viral mutant. The role of inflammatory monocyte in iNOS-dependent control of MCMV was further
confirmed by treatment of mice with the iNOS inhibitor
l-NAME and by blocking of CCL2 chemokine. It is well
established that inflammatory monocytes can give rise to
tissue macrophages and DCs (Guilliams et al., 2014; Italiani
and Boraschi, 2014). Both subsets have been shown to play
a role in virus control and immunoregulation (Farrell et al.,
2015; Gaya et al., 2015; Holzki et al., 2015). Thus, it is possible that these cells also contribute to enhanced control of
the Δm20.1 virus. This particularly refers to macrophages,
as our data show that all three splenic macrophage subsets
selectively up-regulate DNAM-1 upon MCMV infection,
whereas no such up-regulation was observed on DCs (unpublished data). Indeed, the results obtained after clodronate
treatment support the role of other phagocytes.
Inflammatory cytokines promote the production of
CCR2-binding chemokines and regulate monocyte/macrophage emigration from the BM, as well as their recruitment
into the tissues in response to MCMV infection (Hokeness

MATERIALS AND METHODS
Cells
SVEC4-10 (CRL-2181; ATCC), M2 10B4 (CRL1972;
ATCC), J774A.1 (TIB67; ATCC), B12 (immortalized BALB/c fibroblasts), and MEF (mouse embryonic fibroblasts from
BALB/c mice) were cultivated in Dulbecco’s modified Eagle’s medium supplemented with 10 or 3% fetal calf serum.
DC2.4 cells (immortalized DCs) were cultivated in RPMI
medium w/o mercaptoethanol. SP2/O (CRL 1581; ATCC)
cells were cultured in supplemented or plain RPMI medium.
To obtain BMDCs, BMDCs were cultured for 7 d in 10%
RPMI complemented with GM-CSF.
Viruses
The bacterial artificial chromosome (BAC)–derived MCMV,
MW97.01, has previously been shown to be biologically equivalent to the MCMV Smith strain (VR-194 [reaccessioned asVR1399]; ATCC) and is here referred to as WT MCMV (Wagner
et al., 1999). WT MCMV strains and various MCMV mutants
used in these experiments were propagated on MEF, and virus
stocks were prepared as described previously (Brune et al., 2001).
MCMV mutants lacking different sets of genes or gene fragments were generated by site-directed mutagenesis on MCMV
BAC, as described previously for Δ8(m01-m22), Δ1(m01-m17;
Brune et al., 2006), Δm138/fcr-1 mutant (Crnković-Mertens
et al., 1998), and Δm157 mutant (Bubić et al., 2004). The new
MCMV mutants in region m18-m22 were generated on WT
MCMV BAC.To avoid interference with NK cell activation via
Ly49H receptor, a set of mutants in this region was also generated
on the backbone of Δm157 BAC (Bubić et al., 2004). Primers
used for generation of MCMV mutants of the m18-m22 re1846

gion on WT MCMV/C3X background are as follows: Primers
for Δm20.1, 5′-M20_1-ACCTGGCCTATACTCACGTTG
CCGTTGTGCAGGTCCGAGAACATGAGGACGACG
ACGACAAGTAA, 3′-M20_1-GTAAATGGACGGTTATTA
AAAG ATG AGG TCG TGT GAC CTC TGT TACAGG AA
CACTTAACGGCTGA; primers for Δm20.0, 5′-MP ACA
CCCATCC CCTACCATTATG TTT CCC CGG TTCAT
CTCG AGATCC TCAGAG TAA ACT TGG TCT GACAG
TTACC and 3′-MP TGGGCCAACGATCTGGCCGGA
ATGTATCGCTGCGCCGTCTACTTCACCGCCGTG
GACTCCAACGTCAAAGG; primers used for generation of
MCMV mutants on Δm157 background, primers for Δm18
virus, 5′-M18-Kan TCGTCGTTAAGTATTTCTGCAAAG
CATT CGACGT CGTAAT CGC TAACGACGC CAG TG
TTACAACCAATTAACC and 3′-M18-Kan GACACT
GGGCACGGTACCCGAACGAGAGGTTCGAGGGTC
GTCAGAGCGCCCGATTTATTCAACAAAGCCACG;
primers used for Δm19/m20 virus, 5′-M19-Kan ATCATC
GCCACAC CCATCC CCTACCATTATG TTT CCC CG
GTTCATCTCGAGCCAGTGTTACAACCAATTAACC
and 3′-M19-Kan AGGCGAGTCTTCGGAGCTGTACGC
TAGG GCG ATC GCCATCACC CTC TTCACG ATT TA
TTCAACAAAGCCACG; primers used for Δm20/21 virus,
5′-M20-Kan TGAAGAGGGTGATGGCGATCGCCCTAG
CGTACAG CTCCGA AGACTCGCCTGCCAG TGT TA
CAACCAATTAACC and 3′-M21-Kan GTCATGTAAATG
GACG GTTATTAAA AGATGAGGT CGT GTG ACC TC
TGTTACGATTTATTCAACAAAGCCACG; primers used
for Δm22 virus, 5′-M22-Kan TAGCGCCTCGATCGACGA
GCGTCGGACAAAGAAACCGGGAGAAGAAGGCCA
GTGTTACAACCAATTAACC and 3′-M22-Kan TGATCG
GATCGGACGGACCGGACGGACCGCGACTGCTTG
TCGGGCGGGTGCGATTTATTCAACAAAGCCACG;
primers used for Δm19.1(B84) virus, 5′-M19-MP-Kan AAG
ACGC TCG TCT TATAACACC GAC TGACGT TTACT
CCGA
 CTC
 AGG
 ATG
 CCA
 GTG
 TTA
 CAA
 CCA
 ATTAACC
and 3′-M19-MP-Kan AAATCATACCATTCGAGTCCG
ATGT CCG TGT CTCACT TCT GGT TTCTTT GCG AT
TTATTCAACAAAGCCACG; primers used for Δm20.1(B85)
virus, 5′-M20-MP-Kan ACCAACACCTGGCCTATACTC
ACGTTGCCGTTGTGCAGGTCCGAGAACATGCCA
GTGTTACAACCAATTAACC and 3′-M21-Kan GTCATG
TAAATGGACGGTTATTAAAAGATGAGGTCGTGTGAC
CTCTGTTACGATTTATTCAACAAAGCCACG.
Northern blot
Northern blot analysis was performed as described previously
(Juranic Lisnic et al., 2013). In brief, RNA was isolated using
the TRIzol reagent from mock or MCMV-infected MEF
(0.3 PFU/cell). 1 µg of RNA was separated, transferred to
membrane, and cross-linked by UV irradiation. Membranes
were incubated with DIG-labeled probes overnight at 67°C.
Single-stranded RNA probe was generated by in vitro transcription from PCR products amplified with m19–m20
primers (Juranic Lisnic et al., 2013).
MCMV evasion of DNAM-1-dependent immune control | Lenac Rovis et al.
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trol of activation of mononuclear phagocytes by PVR
down-modulation might be beneficial for MCMV-infected newborn mice, particularly keeping in mind that
immune mechanisms that are supposed to contain virus
infection (e.g., NK cells and CD8 T cells) are not fully developed at this postnatal period. Therefore, the fact that the
virus lacking PVR inhibitor is attenuated in neonatally infected mice can be a double-edged sword. Further studies
are needed to assess the significance of viral regulation of
PVR in reducing inflammation, histopathology, and neuronal abnormalities caused by cytokines and other soluble
factors induced by the infection.
In conclusion, our data provide the strongest evidence
so far for CMV control by mononuclear phagocytes and NK
cells in which the DNAM-1–PVR pathway plays an essential
role. In addition, the results demonstrate novel mechanism of
viral regulation of paired receptors, which also differ in affinity to their common ligand. These results may be instrumental to identifying novel intervention targets and in designing
novel vaccines and vaccine vectors. Our data also suggest that
preservation of mononuclear phagocytes in individuals under
immunodepletion regimens could reduce the risk of the primary viral infection and reactivation of latent viruses.

(Yokoyama and Kim, 2008). The following antibodies, purchased from eBioscience or BD, were used: CD3ε (145-2C11),
CD49b (DX5), NKp46 (29A1.4), TIGIT (GIGD7 and R&D
cat.no. FAB7267A), CD96 (6A6 and 630612), DNAM-1
(10E5), IFN-γ (XMG1.2), CD11b (M1/70), CD11c (N418),
CD19 (1D3), F4/80 (BM8), Ly6C (HK1.4), Ly6G (1A8Ly6g), MERTK (DS5MMER), CD169 (3D6.112), SIGNR1
(cat.no. FAB1836P), CD64 (X54-5/7.1), MHCII (NIMR-4),
PVR (TX56), B220 (RA3-6B2), PDCA-1 (eBio927), SAEF710, and iNOS (CXNFT). For iNOS staining of myeloid
cell subsets, splenocytes were incubated for 4 h in 10% RPMI
with Brefeldin A and Monensin (Fig. S1). For IFN-γ staining,
splenocytes were incubated as described for myeloid subsets,
with addition of IL-2 (500 IU/ml). Subsequently, cells were
surface stained, fixed, and permeabilized, followed by intracellular staining. Flow cytometry was performed by FACSAria,
FACSVerse, or FACScan (BD), and data were analyzed using
FlowJo_v10 (Tree Star) software.

Protein expression and purification
Immunogens were subcloned into pQE-30 vector encoding N-6xHis tagged proteins, induced with 1 mM IPTG
in BL21 DE3 cells, and purified under denaturing conditions using AKTA-prime. The pellet was lysed using 6 M
guanidine hydrochloride, 20 mM sodium phosphate, and
500 mM sodium chloride; mixed in 1:1 ratio with the 8 M
urea, 20 mM sodium phosphate, and 500 mM sodium chloride; and then applied to the Ni-NTA column. After elution
(8 M urea, 20 mM sodium phosphate, and 500 mM sodium
chloride, pH 4.0), the immunogen was diluted in 8 M urea,
50 mM sodium phosphate, 300 mM sodium chloride, and
10 mM imidazole (pH 7.4) and polished using Co-NTA column and the (8 M urea, 50 mM sodium phosphate, 300 mM
sodium chloride, and 150 mM imidazole) elution conditions.

Immunofluorescence
B12 cells were infected with 3 PFU/per cell of recombinant MCMV lacking viral Fc receptor encoded by the m138
gene. This virus was used to exclude the possibility of the
rat anti-PVR mAb binding to the viral Fc receptor fcr-1.
The equivalence of the WT MCMV and Δm138 virus with
respect to PVR retention phenomenon was confirmed in a
set of flow cytometry and Western blot analyses. Cells were
supplemented with lactacystin (10 µM) or leupeptin (75 µg/
µl) from the fourth h.p.i., and then fixed and analyzed for
PVR after an additional 12 h. PVR was stained with the antibodies described in the Flow cytometry section, mounted
using Mowiol mounting medium, and analyzed on RT
with Olympus FV300 confocal laser scanning microscope
using a PlanApo 60× NA1.4 oil objective (Olympus) and
FluoView acquisition software.

Generation of anti m20.1 mAbs
BALB/c mice were injected with 50 µg of immunogen in
complete Freund’s adjuvant and, 2 wk later, in incomplete
Freund’s adjuvant. After 2 wk, the sera were screened for the
antibody titer.The best responders were boosted with the immunogen in PBS. 3 d later, spleen cells were collected, and
after lysis of red blood cells, fused with SP2/0 cells. The cells
were seeded in 20% RPMI 1640 medium containing hypoxanthine, aminopterine, and thymidine for hybridoma selection and screened for mAbs using ELISA.
Flow cytometry
Uninfected or cells infected with indicated MCMV strains
were stained for the surface PVR using rat anti–mouse PVR
clone 3F1 (Hycult Biotech), followed by goat anti–rat IgG
F(ab′)2-PE (sc-3829) or goat anti–rat IgG, F(ab’)2-FITC (sc3825). Rat IgG2a isotype control (clone MEL.14) was generated and characterized in our laboratory.
Splenic leukocytes were prepared as previously described, and Fc receptors were blocked with 2.4G2 antibody
JEM Vol. 213, No. 9

Western blot analysis
Cell lysates were prepared using NP-40 lysis buffer (10 mM
Sodium phosphate, pH 7.2, 150 mM sodium chloride, 2 mM
EDTA, 1% NP-40, and protease inhibitors). Proteins, 75–100
µg of lysate, were separated on 10–12% SDS-PAGE. For
EndoH treatment, 75–100 µg of lysate was incubated for 16 h
with 25 mU of EndoH in 0.1 M phosphate buffer at 37°C.
Lactacystin and leupeptin were used as described for Immunofluorescence. Membranes were incubated with anti–mouse
PVR clone 3F1 (Hycult Biotech), anti-actin (EMD Millipore), anti-MCMV m04 (clone m04.10), anti-MCMV M57
(clone M57.01), and anti-MCMV m20.1 (clone m20.1.01;
all generated in our laboratory). All samples were visualized
using the UVITec imaging system.
Coimmunoprecipitation (CoIP)
MEF lysates were prepared as described for Western blot
analysis and incubated overnight at 4°C under rotation with
anti-m20.1 mAb, followed by 1-h incubation with protein
1847
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qPCR
BALB/c MEF was infected with 1 PFU of indicated viruses.
The cells were collected with 2 mM EDTA, washed in PBS,
and lysed in RLT buffer (QIAGEN). RNA was isolated
using RNEasy Plus Mini kit according to manufacturer’s
(QIAGEN)instructions. RNA integrity was visualized on
RNA Bleach gel (Aranda et al., 2012). RNA was treated
with DNaseI (New England Biolabs), and then reverse transcribed using Protoscript II First Strand Synthesis kit (New
England Biolabs) with random primers mix according to
the manufacturer’s protocol. PVR transcript was quantified
in triplicates on Applied Biosystems’ 7500 Instrument using
TaqMan assay (Thermo Fisher Scientific) for mouse PRV
(Mm00493398_m1) with GAPDH as endogenous control
(Mm99999915_g1). No amplification from either PVR or
GAPDH probes was observed in either RT controls or NTC
samples. Relative quantitation was calculated using ΔΔCT
method on 7500 Software V 2.0.5.

G–Sepharose beads (50 µl; GE Healthcare). The precipitates were washed five times (1 ml each) with IP buffers
before the samples were subjected to Western blot analysis. The membranes were incubated with anti–mouse PVR
clone 3F1 (Hycult Biotech).
Cytokine detection
Mouse Cytokine Array Panel A Array kit (R&D Systems) was
used according to the manufacturer’s instructions. In brief,
80–100 µl of sera previously mixed with antibody cocktail
was added to the precoated membranes and incubated overnight. The membranes were incubated with streptavidin. The
results were visualized by ImageQuant imaging system and
analyzed with the ImageJ software (National Institutes of
Health) with dot blot analysis plug-in.

Online supplemental material
Fig. S1 shows gating strategies for mononuclear phagocytes.
Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20151899/DC1.
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Infection conditions, detection of MCMV, and
depletion of cell subsets
Adult mice were injected either i.p. or i.v. with tissue culture–grown recombinant MCMV strains, at indicated doses,
in a volume of 500 µl of PBS. Organs were harvested at indicated time points, and virus titers were determined by a
plaque-forming assay. In vivo depletion of NK cells was performed by i.p. injection of the mAbs to NK1.1 (PK136) or
anti-AGM1 and of mononuclear phagocytes by i.p. injection
of clodronate liposomes (200 µl, 18 h before infection). In
vivo blocking of CCL2 was performed by i.p. injection of the
mAbs to CCL2 (clone 2H5; BioXCell; 200 µg/mouse), 1 d
before infection and on the day of infection. Newborn BALB/c mice were injected i.p. with 400 PFU of either Δm20.1
MCMV mutant generated on Δm157 background or Δm157
MCMV as a control virus in a volume of 50 µl of PBS. Organs
were harvested 11 d p.i., and virus titers were determined by
a plaque-forming assay. In vivo inhibition of NOS: l-NAME
(Sigma-Aldrich) was administered ad libitum in drinking water
(5 mM) starting 3 d before infection. l-NAME solutions were
changed daily. Control groups received only drinking water.
Statistical analysis
Statistical significance of the differences between experimental groups of animals in viral titers was determined by the
two-tailed Mann–Whitney U test and for surface protein expression or intracellular iNOS and IFN-γ detection on different cell subsets by unpaired, two-tailed Student’s t test.
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Figure S1. Gating strategies. Total mouse splenocytes were prepared and stained with indicated antibodies as described in Materials and methods. (A)
Debris (SSC-A vs. FSC-A) and doublets (FSC-H vs. FSC-A) were excluded from total mouse splenocytes. Lineage− cells (gated out using a CD3, CD19, and
NKp46 PI dump channel) were then sub-gated on CD11b+ and F4/80Hi populations. CD11b+ population was sub-gated on CD64+, which was sub-gated on
CD169 and SIGNR1 to distinguish marginal zone (MZ; SIGNR1+) from metallophilic (MM; CD169+) macrophages. F4/80Hi population was sub-gated on MER
TK+ cells, identifying red pulp macrophages (RP). To determine MM and MZ gates, corresponding FMOs were used. (B) Debris, doublets, and Lineage cells
were excluded as in A. Lineage− cells were sub-gated on CD11cHi MHCII+ to identify conventional DCs (cDCs). CD11c− cells were sub-gated on Ly6C CD11b
demonstrating two populations: inflammatory monocytes (IM; Ly6CHi) and neutrophils (Neutro; Ly6C+ CD11bHi). Two populations were further confirmed by
Ly6G expression, as depicted in last blot. (IM, black; Neutro, gray). (C) After exclusion of debris and doublets (as in A), on Lineage− gate (gated out using CD3
and CD19 in PI channel), NK cells were identified as Lin− NKp46+ (NK). Lineage− cells were sub-gated on CD11bint/low CD11c+ after sub-gating on PDCA-1+
B220+ to identify plasmacytoid DCs (pDCs).
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